Uptake Medical Technology Inc.

Uptake Medical Technology Inc. is a San Jose, California-based medical device manufacturer specializing in bronchoscopic thermal vapor ablation (BTVA) systems for pulmonary disease treatment. The company's primary product, InterVapor® (also known as BTVA®), is a non-surgical, non-implant therapeutic system designed to treat severe emphysema and select lung malignancies through vapor ablation technology. The procedure involves delivery of heated, purified water (steam) via a thin bronchoscope inserted through the patient's airway to diseased lung tissue, resulting in tissue ablation and removal via natural healing processes. Treatments typically require less than 15 minutes and can be performed under light sedation in an outpatient bronchoscopy setting. The vapor ablation mechanism targets severely diseased lung regions to improve pulmonary function and breathing capacity in patients with severe emphysema, potentially enhancing quality of life. The company markets its technology as a minimally invasive alternative to surgical lung volume reduction. Note: InterVapor is not currently approved for use in the United States, limiting domestic commercial availability. The company's regulatory and clinical development strategy targets international markets and regulatory approval pathways.